Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concurrent Goserelin During Chemotherapy for Ovarian Function Preservation in Premenopausal Breast Cancer: An Open-Label Randomized Trial

NCT07127315 is registered in ClinicalTrials.gov with Helwan University as lead sponsor.

NCT NCT07127315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07127315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concurrent Goserelin During Chemotherapy for Ovarian Function Preservation in Premenopausal Breast Cancer: An Open-Label Randomized Trial
Lead sponsor
Helwan University
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2022
Completion date
July 1, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chemotherapy, gonadotropin releasing hormone agonists, ovarian function, premenopausal